Thursday, 15 October 2026European Markets
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· March 17, 2026

Zacks Industry Outlook Highlights GoDaddy, Vipshop Holdings, MakeMyTrip and QuinStreet

View original at finance.yahoo.com
Zacks Industry Outlook Highlights GoDaddy, Vipshop Holdings, MakeMyTrip and QuinStreet For Immediate Release Chicago, IL – March 17, 2026 – Today, Zacks Equity Research discusses GoDaddy GDDY, Vipshop Holdings VIPS, MakeMyTrip MMYT and QuinStreet QNST…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Tech giants bring deep pockets, vast infrastructure and enormous user bases, raising the bar for the entire industry

    60% confidence
  • Tariffs and ongoing geopolitical tensions could hurt the industry participants' prospects in the near term

    60% confidence
  • MakeMyTrip is the leading online travel agency in India with a dominant market share of more than 50%

    60% confidence
  • Growth in bookings, primarily driven by strong customer additions and price increases in various domains, has been a key catalyst for GoDaddy

    60% confidence
  • A greater Internet presence in emerging markets, a burgeoning affluent middle class and the accelerated uptake of smartphones are set to aid the Internet – Delivery Services industry participants

    60% confidence
  • Elevated operating expenses related to hiring new employees and sales and marketing strategies to capture more market share are likely to strain margins in the near term

    60% confidence
  • GoDaddy, Vipshop Holdings, MakeMyTrip and QuinStreet are well-positioned for growth due to their sustained efforts in adapting to changing consumer preferences

    60% confidence
  • Persistent macroeconomic uncertainties, protracted inflationary conditions and still-high interest rates remain major challenges

    60% confidence
  • The top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1

    60% confidence
  • Airo has become a key growth driver for GoDaddy, with increasing customer engagement and the successful launch of Airo Plus

    60% confidence
  • Online delivery is yet to expand beyond major metros, underlining lower penetration and significant room for growth

    60% confidence
  • Vipshop Holdings' quarterly results are likely to keep benefiting from its deepening focus on high-margin-generating apparel-related businesses

    60% confidence
  • Amazon continues to strengthen its delivery capabilities, while Alphabet is expanding into food delivery through projects like Wing

    60% confidence
  • Vipshop Holdings' continued efforts to strengthen product offerings and improve product procurement are aiding its financial performance

    60% confidence
  • Top stock-picking strategies have blown away the S&P's +7.7% average gain per year since 2000, with average gains of +48.4%, +50.2% and +56.7% per year

    60% confidence
  • QuinStreet is benefiting from the accelerated shift from an offline to an online business model across industries

    60% confidence
  • MakeMyTrip is well-positioned to benefit from India's economic upswing and expanding middle class

    60% confidence
  • Ad spending is likely to continue increasing, driven by improving business activities

    60% confidence
  • GoDaddy is benefiting from strong momentum across the Applications & Commerce business and expanding its global footprint

    60% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Clinical Catalyst Season: Big-Pharma Data Flow, Regulatory Milestones, and a Thin AI-Drug Fringe
October 2026 conferences (EASD, IGCS, NACFC, HFSA) are producing a dense run of late-stage readouts from Novo Nordisk, Lilly, Roche, Bayer, Vertex and Galderma. Regulatory milestones are scheduled behind them: the ivonescimab BLA PDUFA date on 2026-11-14, FDA acceptance of Roche's vamikibart BLA, and Scholar Rock's EMA resubmission. The AI-and-finance angle is peripheral. It consists of the AI-designed drug Rentosertib and QAIAx, a speculative microcap whose trial claims (the QIII pilot, anticipated 2027-01-01, and a patent update) are forecasts and filings rather than data, so they warrant skepticism.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,375 source documents archived
Query this data → isubstrate.com
Zacks Industry Outlook Highlights GoDaddy, Vipshop Holdings, MakeMyTrip and QuinStreet — Source | Via News | ViaNews EU